4//SEC Filing
Gladstone Michael 4
Accession 0001209191-22-038696
CIK 0001845337other
Filed
Jun 21, 8:00 PM ET
Accepted
Jun 22, 4:47 PM ET
Size
9.5 KB
Accession
0001209191-22-038696
Insider Transaction Report
Form 4
Gladstone Michael
Director
Transactions
- Purchase
Common Stock
2022-06-17$15.00/sh+766,667$11,500,005→ 766,667 total(indirect: See Footnote)
Footnotes (1)
- [F1]The shares are owned directly by Atlas Venture Opportunity Fund II, L.P. ("AVOF II"). Atlas Venture Associates Opportunity II, LP ("AVAO II LP") is the general partner of AVOF II. Atlas Venture Associates Opportunity II, LLC ("AVAO II LLC") is the general partner of AVAO II LP. The Reporting Person is a member of AVAO II LLC and disclaims Section 16 beneficial ownership of such securities held by AVOF II, except to the extent of his pecuniary interest therein, if any.
Documents
Issuer
Day One Biopharmaceuticals, Inc.
CIK 0001845337
Entity typeother
Related Parties
1- filerCIK 0001864256
Filing Metadata
- Form type
- 4
- Filed
- Jun 21, 8:00 PM ET
- Accepted
- Jun 22, 4:47 PM ET
- Size
- 9.5 KB